# Gentuity, LLC

> Medical device manufacturer record on deviCERTS, compiled from public registries. Gentuity, LLC is a medical device manufacturer, with 8 devices listed in FDA 510(k) and FDA GUDID (FDA Class II) and 1 FDA recall as of 16 Nov 2026.

- Canonical page: <https://devicerts.com/manufacturers/gentuity-llc>
- Country: United States (FDA applicant, unverified)
- Role: Manufacturer
- Registrations: FDA
- FDA FEI: 3021630097
- DUNS: 077509759

## Figures

- Devices: 8
- FDA recalls (matched to the firm by name): 1, 1 ongoing

## Registry facts

*Every device of the manufacturer. A device listed in two registries counts in both.*

- Registries: FDA 510(k) 4, FDA GUDID 4
- Device classes: FDA Class II 8

## Devices

The first 8 of 8, in the order of the canonical page, which lists them all.

- [Gentuity HF-OCT Imaging System SW 23.3.13](https://devicerts.com/devices/gentuity-hf-oct-imaging-system-gentuity-imaging-sys) · Class II · GUDID · status: Active
- [Gentuity Gentuity Review Station](https://devicerts.com/devices/gentuity-g80-01) · Class II · GUDID · status: Active
- [Vis-Rx Prime G31](https://devicerts.com/devices/vis-rx-prime-g31-01) · Class II · GUDID · status: Active · open recall
- [Vis-Rx US Catheter Kit G30-01](https://devicerts.com/devices/vis-rx-us-catheter-kit-g30) · Class II · GUDID · status: Active
- [Gentuity® HF-OCT Imaging System with Vis-Rx Prime® Micro-Imaging Catheter](https://devicerts.com/devices/gentuity-r-hf-oct-imaging-system-with-vis-rx-prime-r-micro-i-dqo) · ref K242966 · Class II · 510(k) · status: Active · decision 2025-01-31 · open recall
- [Gentuity HF-OCT Imaging System with Vis-Rx Micro-Imaging Catheter](https://devicerts.com/devices/gentuity-hf-oct-imaging-system-with-vis-rx-micro-imaging-cat-nqq) · ref K192922 · Class II · 510(k) · status: Active · decision 2020-02-20
- [Gentuity® HF-OCT Imaging System with Vis-Rx® Micro-Imaging Catheter](https://devicerts.com/devices/gentuity-r-hf-oct-imaging-system-with-vis-rx-r-micro-imaging-dqo) · ref K230620 · Class II · 510(k) · status: Active · decision 2023-08-08
- [HF-OCT Imaging System with Vis-RX Micro-Imaging Catheter (G10 (HF-OCT Console), G30 (Vis-Rx Micro-Imaging Catheter))](https://devicerts.com/devices/hf-oct-imaging-system-with-vis-rx-micro-imaging-catheter-g10-nqq) · ref K242239 · Class II · 510(k) · status: Active · decision 2024-08-16

## FDA recalls (matched by name, newest first)

- Z-1823-2026 · Class II · Ongoing · initiated 2026-03-23 · product code DQO: The potential for repeated frames during HF-OCT pullback when using the Gentuity HF-OCT Console (software version 21.11 to 23.3.13) with the Vis-Rx and Vis-Rx Prime catheters. This correction is intended to ensure that users are fully informed of how to recognize, avoid, and mitigate this condition to maintain accurate longitudinal (length) measurements during OCT imaging.

## Source and citation

- Cite as: Gentuity, LLC. deviCERTS medical device catalogue. https://devicerts.com/manufacturers/gentuity-llc (data as of 2026-11-16).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [FDA GUDID](https://accessgudid.nlm.nih.gov/), [FDA registration and listing](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- FDA recall data as of: 2026-11-01
- Data as of: 2026-11-16
- JSON: <https://devicerts.com/manufacturers/gentuity-llc.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/manufacturers/gentuity-llc
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
